EQUILLIUM, INC. Current Liabilities
EQUILLIUM, INC. (EQ) had Current Liabilities of $2.48 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $2.48M.
- 2026-03-31: Liabilities, Current $3.35M.
- 2025-12-31: Liabilities, Current $2.93M.
- 2025-09-30: Liabilities, Current $3.09M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.93M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.23M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.00M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $6.36M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $11.06M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $20.17M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $22.21M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $27.57M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $28.20M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $25.22M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $32.02M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $32.04M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $14.93M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $15.19M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $13.11M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $8.91M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $7.78M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.98M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $7.42M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $7.25M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $5.14M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $3.39M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $3.71M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $3.88M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $4.27M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.66M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $3.05M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $2.03M 10-K · filed 2020-03-26 | $2.03M 10-K · filed 2019-03-27 |
| 2018-09-30 | $2.68M 10-Q · filed 2018-11-15 | |
| 2017-12-31 | $568.82K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |